The Velcade Three

The Velcade Three

View our EDM

We are proud that 68 local constituents have signed an Early Day Motion supporting our campaign for access to Velcade.

Click here to view EDM 1819.

Latest news »

Minutes from Meeting with Ann Keen (Health Minister) 20/07/09

30th September 2008

Last July (20/07/09) I (Jacky), met with Ann Keen to discuss a few outstanding issues that The Velcade Three had and to share some ideas that we felt may aid smoother transition when Consultants are applying for Velcade for Myeloma sufferers.

Notes from Health Minister Ann Keen’s meeting with Ms Jacky Pickles

30th September 2008

Ms Pickles began the meeting by stating that she had previously met with Sir Mike Rawlins, Chairman of the National Institute for Health and Clinical Excellence (NICE) and Professor Mike Richards, National Cancer Director.

Contact your local MP

Locate and contact your local MP on the UK Parliament website and support The Velcade Three.

Contact Myeloma UK

Myeloma UK provides support and information to all those affected by myeloma.

About The Velcade Three

Jacky Pickles, Janice Wrigglesworth and Marie Morton are three women from Yorkshire who suffer from multiple myeloma - a type of blood cancer. Our fight for access to the life prolonging drug Velcade has been widely reported in the media and we became known as “The Velcade Three”.

About Myeloma and Velcade

  • Myeloma is a cancer of the plasma cells, which attacks and destroys bone, damages the immune system and causes renal failure.
  • The most common symptoms include bone pain, infections and fatigue.
  • Myeloma is currently incurable, but is treatable.
  • Nearly 4,000 new cases will be diagnosed in the UK this year and there are between 14,000 - 20,000 people living with myeloma at any one time in the UK.
  • Public awareness of the disease is very low, despite Myeloma being more prevalent than all but one form of leukaemia and accounting for 15% of all blood cancers.

VELCADE - the latest treatment for Multiple Myeloma is the most effective drug in the treatment of this disease for decades, giving phenomenal results in those who have already been treated.